Navigation Links
OmniPod(R) Insulin Management System Selected as a Finalist for the 2009 Edison Best New Product Awards(TM)
Date:2/11/2009

Prestigious Awards Recognize Excellence in New Product Development, Marketing and Innovation

BEDFORD, Mass., Feb. 11 /PRNewswire-FirstCall/ -- The OmniPod(R) Insulin Management System, designed and produced by Insulet Corporation (Nasdaq: PODD), has been selected as a finalist for the prestigious 2009 Edison Best New Product AwardsTM. The awards are among the most elite accolades honoring excellence in new product development, marketing, and innovation. Strategic implementation partners for the 2009 awards program include the Thomas Edison Papers at Rutgers University, the Marketing Executives Networking Group (MENG) and The MIT/Stanford Venture Lab (VLAB).

The OmniPod(R) Insulin Management System is the first and only continuous insulin delivery system of its kind on the market. The OmniPod System offers people living with insulin-requiring diabetes all the benefits of insulin pump therapy, with unprecedented freedom, comfort and ease in managing their diabetes. Unlike conventional insulin pumps, the OmniPod System has no tubing and features automated, virtually pain-free insertion. It has just two, wireless components: the Pod - a, compact, lightweight, self-adhesive insulin delivery device that is worn discreetly on the skin beneath clothing; and the Personal Diabetes Manager - a wireless, menu-driven, hand-held device that programs the Pod.

The Edison Best New Product Awards, sponsored this year by Google, The Nielsen Company and Steelcase, focus on new products and services that excel in marketplace innovation, marketplace success, technological innovation, market structure innovation, and societal impact. These criteria align with Edison's own innovation best practices, called the Five Competencies of Innovation. MENG members nationwide cast their ballots for entries they deemed worthy of being linked to the Edison name.

"We are honored that the OmniPod System has been recognized for its innovative design and the positive impact it has on the lives of people with diabetes," said Duane DeSisto, president and CEO of Insulet Corporation. "When we created the OmniPod, we started with a blank slate and took a customer-centric approach to designing a new insulin delivery system. Its tubing-free, wireless design makes it totally discreet and the Pod is watertight and durable enough to be worn by many professional athletes. The OmniPod's automated, virtually pain-free insertion means customers never see or handle an insertion needle."

"Innovative, collaborative, passionate, and persistent are just a few of the many characteristics that describe the finalists for the 2009 Edison Best New Product Awards," stated Sarah Miller Caldicott, great grandniece of Thomas Edison, co-author of Innovate Like Edison and Chairperson of the Edison Awards Steering Committee. "All of our 2009 finalists, each in different ways, exemplify the very best in innovation."

Gold, Silver and Bronze winners will be announced at an Awards Gala on April 1, 2009 at the Computer History Museum in Mountain View, California. To register to attend, visit www.edisonawards.com/Awards/2009EdisonAwards.html.

About The Edison Awards:

The Edison Best New Products Award(TM) recognizes the persistence and excellence Thomas Edison personified, qualities which have allowed America to remain in the forefront of innovation, creativity, and ingenuity in the global economy. The Edison Achievement Award(TM) honors business leaders who have displayed the persistence, collaboration, and creativity necessary to promote successful innovation in their organizations. For more information about The Edison Awards, visit www.edisonawards.com.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.

    Media Contacts:
    Mark Sahl on behalf of Insulet
    609-992-5205
    msahl@lazarpartners.com

    Chris Faust on behalf of The Edison Awards
    973-226-4379
    cfaust@fast-lane.net


'/>"/>
SOURCE Insulet Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R)
2. Insulin May Protect Against Alzheimers
3. Intensive Insulin Therapy Reduces Mortality in Sick Kids
4. High insulin levels raise risk of breast cancer in postmenopausal women
5. High Insulin May Boost Odds of Breast Cancer
6. Vitamin K Slows Insulin Resistance in Older Men
7. Vitamin K linked to insulin resistance in older men
8. Lilly Announces Major Donation of Insulin to International Diabetes Federations Life for a Child Program; Initial Focus Will Be on Sub-Saharan Africa
9. Completely novel action of insulin unveiled
10. Impact of insulin pump under study
11. Diabetes Spectrum Reports a Study Assessing the i-port(R) Injection Port for Administration of Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... Mateo, CA (PRWEB) , ... April 28, 2017 , ... ... Area cities as diverse as Millbrae, Burlingame, and Palo Alto, is proud to announce ... allow interested persons to bookmark and read organized content on topics such as home ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement to create ... by the continuing support of the Jane and Leonard Korman Family Foundation. The ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... Gasby the 2017 Public Leadership in Neurology Award (PLINA). The couple joins a ... Tedy Bruschi, Vice President Walter Mondale, actor Michael J. Fox and former U.S. ...
(Date:4/27/2017)... Malibu, CA (PRWEB) , ... April 27, 2017 , ... ... United States with an oil many times purer and more potent than the market ... mountain air of Gstaad, Switzerland, as well as a patented chromatography process for extraction, ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... today released the podcast, “Make Plans for MACRA,” highlighting the impact ... the physician's office and how physicians and other clinicians are reimbursed for the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Zimmer Biomet Holdings, Inc. (NYSE ... today announced that it will be participating in the ... the InterContinental Hotel in Boston, Massachusetts ... present at 11:20 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .  ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 Research ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ... to their offering. ... market for drug delivery technologies will rise from USD 20 Billion ... Global Drug Delivery Technologies - Innovation Driven by Rapidly ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
Breaking Medicine Technology: